DanielSDickersonMDPhD, FAAFP

Research • Lenexa, KS

Medical Director / Principal Investigator Phase 1 & Phase 2 Clinical Research Trials

Join to view full profile

Dr. Dickerson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Dickerson's full profile

Already have an account?

Office
9755 Ridge Dr
Lenexa, KS 66219
Phone+1 913-410-2973
Is this information wrong?

Education & Training

University of Kansas School of MedicineResidency, Family Medicine, 1996 - 1999
University of Kansas School of MedicineClass of 1996
University of MissouriPhD, Chemistry-Biochemistry, 1987 - 1994

Certifications & Licensure

KS State Medical License 1999 - 2024

Awards, Honors, & Recognition

Rainbow Award (Hero in Medicine) Kansas University School of Medicine, 2006
Preceptor of the Year Kansas University School of Medicine, 2012
Teacher Development Award American Academy of Family Physicians Foundation, 2005
Medical Student Education Recognition Award University of Kansas School of Medicine, 2005
Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Join now to see all

Clinical Trials

Bioequivalence of Duvelisib and Food Effect on Pharmacokinetics of IPI-145 Start of enrollment: 2014 Nov 01
Completed
Phase 1
Study of PF614 Compared to OxyContin® in Healthy Volunteers Start of enrollment: 2016 Nov 16
Completed
Phase 1
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of SUVN-D4010 in Healthy Subjects Start of enrollment: 2015 Jul 01
Completed
Phase 1
A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer Start of enrollment: 2016 May 19
Active, not recruiting
Phase 2
A Study to Evaluate LY3202328 in Overweight Healthy Participants and Dyslipidemia Start of enrollment: 2016 Mar 01
Completed
Phase 1
A Study of EDP 305 in Healthy Subjects and Subjects With Presumptive NAFLD Start of enrollment: 2016 Sep 01
Completed
Phase 1
A Study to Investigate the Effect of Food, Gender, and Age on the Pharmacokinetic Profile of SUVN-D4010 in Healthy Subjects Start of enrollment: 2017 Jan 23
Completed
Phase 1
Drug-drug Interaction Study Between EDP-305, Midazolam, Caffeine and Rosuvastatin in Healthy Volunteers. Start of enrollment: 2017 May 11
Completed
Phase 1
A Study of EDP-938 in Healthy Subjects Start of enrollment: 2017 Dec 07
Completed
Phase 1
A Study to Evaluate the Single Dose Safety, Tolerability and Pharmacokinetics of IV BCX4430 Start of enrollment: 2018 Dec 10
Completed
Phase 1
A Study of EDP-514 in Healthy Subjects (Part 1) and Patients With Chronic Hepatitis B Virus Infection (Part 2) Start of enrollment: 2019 Jun 26
Completed
Phase 1
Drug-Drug Interaction Study Between EDP-938, Tacrolimus, Dabigatran, Rosuvastatin and Midazolam in Healthy Subjects Start of enrollment: 2020 Jul 08
Completed
Phase 1
A First-In-Human SAD and MAD Study to Evaluate the Safety, Tolerability, PK and PD of SC Administered ALTB-268 in Healthy Volunteers Start of enrollment: 2023 Jan 17
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

14 citations
Selective expansion of regulatory T cells by NKTR-358 in healthy volunteers and patients with systemic lupus erythematosus.
Christie Fanton, Richard Furie, Vishala Chindalore, Robert Levin, Isam Diab, Neha Dixit, Cat Haglund, Jacqueline Gibbons, Nathan Hanan, Daniel Dickerson, Jonathan Zale...> ;Journal of Translational Autoimmunity. 2022 Jan 1
4 citations
A Randomised Controlled Trial Comparing the Pharmacokinetics and Tolerability of the Proposed Adalimumab Biosimilar MSB11022 Delivered via Autoinjector and Pre-filled ...
Ahad Sabet, Daniel S Dickerson, Eugenia E Kunina, Anna Lucia Buccarello, Joëlle Monnet> ;Rheumatology and Therapy. 2022 Apr 1
11 citations
Safety and Pharmacokinetics in Human Volunteers of Taniborbactam (VNRX-5133), a Novel Intravenous β-Lactamase Inhibitor.
James A. Dowell, Daniel S Dickerson, Tim Henkel> ;Antimicrobial Agents and Chemotherapy. 2021 Aug 9
11 citations
A large multicentre, randomized, double-blind, cross-over study in healthy volunteers to compare pharmacokinetics, pharmacodynamics and safety of a pegfilgrastim biosi...
Anne Bellon, Jessie Wang, Andrej Skerjanec, Maria Velinova, Daniel Dickerson, Ahad Sabet, Ly Ngo, Terry O'Reilly, Charles Tomek, Steven Schussler, Stefanie Schier-Mumz...> ;British Journal of Clinical Pharmacology. 2020 Feb 21
21 citations
A Phase I Study to Assess the Effect of Speed of Injection on Pain, Tolerability, and Pharmacokinetics After High-volume Subcutaneous Administration of Gantenerumab in...
Agnès Portron, Paul Jordan, Kristy Draper, Christopher Muenzer, Daniel Dickerson, Thijs van Iersel, Carsten Hofmann> ;Clinical Therapeutics. 2020 Jan 1
52 citations
A Phase 1, Randomized, Single-Ascending-Dose Study To Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S, an Anti-Staphylococcus aureus Thiomab An...
Melicent C. Peck, Michael E. Rothenberg, Rong Deng, Nicholas Lewin-Koh, Gaohong She, Amrita V. Kamath, Montserrat Carrasco-Triguero, Ola Saad, Aide Castro, Lisa Teufel...> ;Antimicrobial Agents and Chemotherapy. 2019 May 24
40 citations
Phase 1 trial of vamorolone, a first-in-class steroid, shows improvements in side effects via biomarkers bridged to clinical outcomes
Eric P. Hoffman, Valerie Riddle, Maxime A. Siegler, Daniel Dickerson, Miroslav Backonja, William G. Kramer, Kanneboyina Nagaraju, Heather Gordish-Dressman, Jesse M. Da...> ;Steroids. 2018 Mar 8
2 citations
Pharmacokinetics and Abuse Potential of Benzhydrocodone, a Novel Prodrug of Hydrocodone, After Intranasal Administration in Recreational Drug Users.
Travis C Mickle, Sven M Guenther, Andrew C Barrett, Kathryn Ann Roupe, Jing Zhou, Daniel Dickerson, Lynn R Webster> ;Pain Medicine. 2018 Dec 1
7 citations
Dopamine D2 receptor stimulation alters G-protein expression in rat pituitary intermediate lobe melanotropes.
Scott A. Sands, Daniel S. Dickerson, Stephen J. Morris, Bibie M. Chronwall> ;Endocrine. 1997 Jun 1
13 citations
Melanotrope dopamine D2 receptor isoform expression in the developing rat pituitary.
Bibie M. Chronwall, Scott A. Sands, Daniel S. Dickerson, Keith A. Gary> ;International Journal of Developmental Neuroscience. 1996 Apr 1
13 citations
Regulation of heterogeneity in D2 dopamine receptor gene expression among individual melanotropes in the rat pituitary intermediate lobe.
Bibie M. Chronwall, Daniel S. Dickerson, Belinda S. Huerter, William R. Millington> ;Molecular and Cellular Neurosciences. 1994 Feb 1
15 citations
POMC mRNA levels in individual melanotropes and GFAP in glial-like cells in rat pituitary.
Daniel S. Dickerson, Belinda S. Huerter, Stephen J. Morris, Bibie M. Chronwall> ;Peptides. 1994 Jan 1
5 citations
Plasticity and Ontogeny of Melanotrope D2A Dopamine Receptor mRNA and Isoform Protein Expression
Bibie M. Chronwall, Daniel S. Dickerson, Keith A. Gary> ;Annals of the New York Academy of Sciences. 1993 May 1
Join now to see all

Committees

Chairman, Kansas Academy of Family Physicians Governmental Advocacy Committee 2015 - Present
School Board Member, Eudora Board of Education 2011 - 2015
Chief of Family Medicine, Lawrence Memorial Hospital Executive Committee 2005 - 2009

Professional Memberships

American Academy of Family Physicians - AAFP
Fellow

Industry Relationships

Research Physician, PRA HealthScences2014 - Present